Evidence map›Paper›PMID 39233827›Full record

ArticleFrontiers in aging neuroscience2024

Metabolome and transcriptome integration reveals cerebral cortical metabolic profiles in rats with subarachnoid hemorrhage.

Haoran Lu, Teng Xie, Shanshan Wei, Yanhua Wang, Huibing Li, Baochang Luo, Xiaohong Qin, Xizhi Liu, Zilong Zhao, Zhibiao Chen and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Haoran Lu *Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Teng Xie *Department of Neurosurgery, Hanchuan Renmin Hospital, Hanchuan, China.
Shanshan Wei *Department of Oncology, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Yanhua WangDepartment of Neurosurgery, Hanchuan Renmin Hospital, Hanchuan, China.
Huibing LiDepartment of Neurosurgery, Hanchuan Renmin Hospital, Hanchuan, China.
Baochang LuoDepartment of Neurosurgery, Hanchuan Renmin Hospital, Hanchuan, China.
Xiaohong QinDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Xizhi LiuDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Zilong ZhaoDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Zhibiao ChenDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Rui DingDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subarachnoid hemorrhage (SAH) is a severe subtype of hemorrhagic stroke. The molecular mechanisms of its secondary brain damage remain obscure. To investigate the alterations in gene and metabolite levels following SAH, we construct the transcriptome and metabolome profiles of the rat cerebral cortex post-SAH using whole transcriptome sequencing and untargeted metabolomics assays. Transcriptomic analysis indicated that there were 982 differentially expressed genes (DEGs) and 540 differentially expressed metabolites (DEMs) between the sham group and SAH 1d, and 292 DEGs and 254 DEMs between SAH 1d and SAH 7d. Most notably, DEGs were predominantly involved in the activation of immune and inflammatory pathways, particularly the Complement and coagulation cascades, TNF signaling pathway, and NOD-like receptor signaling pathway. Metabolic analysis revealed that the metabolic pathways of Arginine and proline, Arachidonic acid, Folate biosynthesis, Pyrimidine, and Cysteine and methionine were remarkably affected after SAH. Metabolites of the above pathways are closely associated not only with immune inflammation but also with oxidative stress, endothelial cell damage, and blood-brain barrier disruption. This study provides new insights into the underlying pathologic mechanisms of secondary brain injury after SAH and further characterization of these aberrant signals could enable their application as potential therapeutic targets for SAH.

Indexed as

inflammationmetabolomesecondary brain injurysubarachnoid hemorrhagetranscriptome

Identifiers

PMID39233827
PMCPMC11371592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.